Peripheral Vascular Devices Market Report Suite - United States - 2020-2026 - MedSuite

1.1.1 Step 1: Project Initiation & Team Selection
1.1.2 Step 2: Prepare Data Systems and Perform Secondary Research
1.1.3 Step 3: Preparation for Interviews & Questionnaire Design
1.1.4 Step 4: Performing Primary Research
1.1.5 Step 5: Research Analysis: Establishing Baseline Estimates
1.1.6 Step 6: Market Forecast and Analysis
1.1.7 Step 7: Identify Strategic Opportunities
1.1.8 Step 8: Final Review and Market Release
1.1.9 Step 9: Customer Feedback and Market Monitoring

2.1 Basic Anatomy
2.2 Disease Treatments & Diagnostics
2.2.1 Aortic Aneurysms
2.2.2 Atherosclerosis
2.2.3 Peripheral Arterial Disease (Pad)
2.2.4 Deep Vein Thrombosis (Dvt)
2.2.5 Pulmonary Embolism (Pe)
2.3 Patient Demographics
2.3.1 Aortic Aneurysms
2.3.2 Atherosclerosis
2.3.3 Peripheral Arterial Disease (Pad)
2.3.4 Deep Vein Thrombosis (Dvt)
2.3.5 Pulmonary Embolism (Pe)

3.1 Introduction
3.2 Product Portfolios
3.2.1 Peripheral Vascular Stent
3.2.2 Venous Stent
3.2.3 Percutaneous Transluminal Angioplasty (Pta) Balloon
3.2.4 Drug-Coated Balloon
3.2.5 Atherectomy Device
3.2.6 Chronic Total Occlusion (Cto) Device
3.2.7 Intravascular Lithotripsy
3.2.8 Surgical Graft
3.2.9 Stent Graft
3.2.10 Embolic Protection Device
3.2.11 Peripheral Thrombus Management Device
3.2.12 Inferior Vena Cava Filter
3.2.13 Carotid Shunt
3.2.14 Diagnostic and Interventional Catheters
3.2.15 Diagnostic and Interventional Guidewire
3.2.16 Introducer Sheath
3.2.17 Vascular Closure Device (Vcd)
3.2.18 Transcatheter Embolization Device
3.2.19 Peripheral Ivus Catheter
3.3 Regulatory Issues and Recalls
3.3.1 Abbott
3.3.1.1 Carotid Shunt
3.3.1.2 Vascular Closure Device
3.3.2 Argon Medical
3.3.2.1 Introducer Sheaths
3.3.3 Arrow International
3.3.3.1 Introducer Sheaths
3.3.4 Atrium Medical
3.3.4.1 Peripheral Vascular Stent
3.3.5 Bd
3.3.5.1 Inferior Vena Cava Filter
3.3.5.2 Introducer Sheaths
3.3.5.3 Stent Graft
3.3.6 Boston Scientific
3.3.6.1 Atherectomy Devices
3.3.6.2 Diagnostic and Interventional Catheters
3.3.6.3 Introducer Sheaths
3.3.6.4 Peripheral Thrombus Management Devices
3.3.7 Cardinal Health
3.3.7.1 Vascular Closure Devices
3.3.8 Cardiovascular System (C.S.I.)
3.3.8.1 Atherectomy Devices
3.3.9 Cook Medical
3.3.9.1 Diagnostic and Interventional Catheters
3.3.9.2 Introducer Sheaths
3.3.9.3 Inferior Vena Cava Filters
3.3.9.4 Peripheral Vascular Stents
3.3.9.5 Stent Grafts
3.3.10 Cordis (Cardinal Health)
3.3.10.1 Diagnostic and Interventional Catheters
3.3.10.2 Inferior Vena Cava Filters
3.3.10.3 Peripheral Stents
3.3.11 Endologix
3.3.11.1 Stent Grafts
3.3.12 Edwards Lifesciences
3.3.12.1 Chronic Total Occlusion Devices
3.3.13 Maquet
3.3.13.1 Pta Balloons
3.3.14 Medtronic
3.3.14.1 Carotid Shunts
3.3.14.2 Diagnostic and Interventional Catheters
3.3.14.3 Pta Balloon Catheters
3.3.14.4 Peripheral Stents
3.3.14.5 Stent Grafts
3.3.14.6 Transcatheter Embolization Devices
3.3.15 Spectranetics (Philips)
3.3.15.1 Atherectomy Devices
3.3.15.2 Chronic Total Occlusion Devices
3.3.16 Shockwave Medical, Inc.
3.3.16.1 Intravascular Lithotripsy
3.3.17 Terumo
3.3.17.1 Introducer Sheaths
3.3.17.2 Pta Balloon Catheters
3.3.18 Other Companies
3.3.18.1 Atherectomy Devices
3.3.18.2 Introducer Sheaths
3.3.18.3 Pta Balloon Catheters
3.3.18.4 Peripheral Ivus Catheters
3.3.18.5 Stent Grafts
3.3.18.6 Vascular Closure Devices (Vcd)
3.4 Clinical Trials
3.4.1 Abbott
3.4.1.1 Peripheral Vascular Stent
3.4.1.2 Other Peripheral Vascular Related Studies
3.4.2 B. Braun
3.4.2.1 Diagnostic and Interventional Catheters
3.4.2.2 Peripheral Vascular Stent
3.4.3 Boston Scientific
3.4.3.1 Atherectomy Devices
3.4.3.2 Drug-Coated Balloons
3.4.3.3 Peripheral Vascular Stents
3.4.3.4 Other Peripheral Vascular Related Studies
3.4.3.5 Venous Stents
3.4.4 C.R. Bard (Bd)
3.4.4.1 Diagnostic and Interventional Catheters
3.4.4.2 Drug-Coated Balloons
3.4.4.3 Venous Stents
3.4.4.4 Other Peripheral Vascular Related Studies
3.4.5 Cardinal Health
3.4.5.1 Other Peripheral Vascular Related Studies
3.4.6 Cook Medical
3.4.6.1 Drug-Eluting Stents
3.4.6.2 Inferior Vena Cava Filters
3.4.6.3 Peripheral Vascular Stents
3.4.6.4 Venous Stents
3.4.7 Cordis (Cardinal Health)
3.4.7.1 Peripheral Vascular Stents
3.4.8 Medtronic
3.4.8.1 Atherectomy Devices
3.4.8.2 Drug-Coated Balloons
3.4.8.3 Other Peripheral Vascular Related Studies
3.4.9 Merit Medical
3.4.9.1 Stent Grafts
3.4.10 Philips/Spectranetics
3.4.10.1 Atherectomy Devices
3.4.10.2 Peripheral Ivus Catheters
3.4.10.3 Spectranetics
3.4.10.3.1 Drug-Coated Balloons
3.4.10.3.2 Atherectomy Devices
3.4.11 Shockwave Medical, Inc.
3.4.11.1 Lithoplasty System
3.4.12 Surmodics
3.4.12.1 Drug-Coated Balloons
3.4.13 Terumo
3.4.13.1 Drug-Coated Balloons
3.4.13.2 Peripheral Vascular Stents
3.4.14 W.L. Gore
3.4.14.1 Peripheral Vascular Stents
3.4.14.2 Stent Grafts
3.4.14.3 Expandable Balloons
3.4.15 Other Companies
3.4.15.1 Carotid Shunt / Endarterectomy
3.4.15.2 Drug-Coated Balloons
3.4.15.3 Peripheral Vascular Stents
3.4.15.4 Other Peripheral Vascular Related Studies

4.1 Introduction
4.1.1 Atherosclerosis
4.1.2 Peripheral Arterial Disease (Pad)
4.2 Market Overview
4.3 Trend Analysis by Segment
4.4 Drivers and Limiters
4.4.1 Market Drivers
4.4.2 Market Limiters
4.5 Competitive Market Share Analysis
4.6 Mergers and Acquisitions
4.7 Company Profiles
4.7.1 Abbott
4.7.2 Becton Dickinson (Bd)
4.7.3 Boston Scientific
4.7.4 Cardinal Health
4.7.4.1 Cordis (Cardinal Health)
4.7.5 Cook Medical
4.7.6 Maquet
4.7.7 Medtronic
4.7.8 Teleflex
4.7.9 Terumo Interventional System (Tis)
4.7.10 W.L. Gore
4.8 SWOT Analysis
4.8.1 Abbott
4.8.2 B. Braun
4.8.3 Boston Scientific
4.8.4 Bd
4.8.5 Cardinal Health
4.8.6 Cook Medical
4.8.7 Integra Lifesciences
4.8.8 Maquet
4.8.9 Medtronic
4.8.10 Merit Medical
4.8.11 Phillips
4.8.12 Teleflex
4.8.13 Terumo
4.8.14 W.L. Gore

5.1 Introduction
5.2 Procedures
5.2.1 Total Peripheral Vascular Procedures
5.2.2 Total Peripheral Vascular Procedures by Device Type, Indication, Intervention & Care Setting
5.2.2.1 Above-The-Knee Procedures
5.2.2.1.1 Above-The-Knee Stent Procedures
5.2.2.1.2 Above-The-Knee Poba Procedures by Care Setting
5.2.2.1.3 Above-The-Knee Dcb Procedures by Care Setting
5.2.2.1.4 Above-The-Knee Atherectomy Without Stent Procedures by Care Setting
5.2.2.1.5 Above-The-Knee Atherectomy With Stent Procedures by Care Setting
5.2.2.2 Below-The-Knee Procedures
5.2.2.2.1 Below-The-Knee Stent Procedures by Device Type
5.2.2.2.2 Below-The-Knee Stent Procedures by Care Setting
5.2.2.2.3 Below-The-Knee Poba Procedures by Care Setting
5.2.2.2.4 Below-The-Knee Dcb Procedures by Care Setting
5.2.2.2.5 Below-The-Knee Atherectomy Without Stent Procedures by Care Setting
5.2.2.2.6 Below-The-Knee Atherectomy With Stent Procedures by Care Setting
5.2.2.3 Iliac Procedures
5.2.2.3.1 Iliac Stent Procedures by Device Type
5.2.2.3.2 Iliac Stent Procedures by Care Setting
5.2.2.3.3 Iliac Poba Procedures by Care Setting
5.2.2.4 Av Access Procedures
5.2.2.4.1 Av Access Covered Stent Procedures by Care Setting
5.2.2.4.2 Av Access Poba Procedures by Care Setting
5.2.2.4.3 Av Access Dcb Procedures by Care Setting
5.2.2.5 Renal Procedures
5.2.2.6 Carotid Procedures
5.2.3 Peripheral Vascular Stent Procedures
5.2.3.1 Peripheral Arterial Stent Procedures by Stent Type
5.2.3.1.1 Bare-Metal Stent Procedures
5.2.3.1.2 Covered Stent Procedures
5.2.3.1.3 Drug-Eluting Stent Procedures
5.2.4 Peripheral Venous Stent
5.2.5 Pta Balloon Catheter Procedures
5.2.6 Drug-Coated Balloon Procedures
5.2.6.1 Drug-Coated Balloon Procedures by Indication
5.2.7 Atherectomy Procedures
5.2.7.1 Atherectomy Procedures by Device Type